Clinical Trial Update: Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating trabectedin in young patients with recurrent or refractory soft tissue sarcoma or Ewing's family tumors; study completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Peripheral Primitive Neuroectodermal Tumor
• Rhabdomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Trabectedin (trabectedin)

Snippet

Sponsor: Children's Oncology Group | Conditions: Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2014-01-27